We have previously demonstrated that insulin-like growth factor 1 (IGF1) induces eukaryotic initiation factor 2B (eIF2B) activation in neuronal cells through the phosphatidylinositol 3 kinase/glycogen synthase kinase 3 pathway as well as by activation of the mitogen-activated protein kinase (MAPK)-activating kinase (MEK)/ MAPK signaling pathway (Quevedo, C., Alcá zar, A., and Salinas, M. (2000) J. Biol. Chem. 275, 19192-19197). This paper addresses the mechanism involved in IGF1-induced eIF2B activation via the MEK/MAPK cascade in cultured neurons treated with IGF1 and demonstrates that extracellular signal-regulated MAP kinase 1 and 2 (ERK1 and -2) immunoprecipitates of IGF1-treated neuronal cells promote this activation. This effect did not directly result from eIF2B phosphorylation by ERK immunoprecipitates. In addition, recombinant ERK1 and -2 neither activate eIF2B nor phosphorylate it. Endogenous protein phosphatase 1 and 2A catalytic subunits (PP1C and PP2AC, respectively) were co-immunoprecipitated with ERK1 and -2, and the association of ERK with PP1C was stimulated by IGF1 treatment, resulting in increased PP1 activity. ERK immunoprecipitates incubated with PP1 inhibitors did not activate eIF2B, indicating that PP1C activates eIF2B. In vitro experiments with phosphorylated eIF2B showed that recombinant PP1C (␣ isoform) dephosphorylates and activates eIF2B. Paralleling eIF2B activation, IGF1 treatment induced PP1 activation in a MEK/MAPK-dependent fashion. Moreover, the treatment of neurons with the PP1 inhibitor tautomycin inhibited PP1 activation and prevented IGF1-induced eIF2B activation. These findings strongly suggest that IGF1-induced eIF2B activation in neurons is effected by PP1, the activation of which is mediated by the MEK/MAPK signaling pathway.The pathway through which growth factors promote their effects in protein synthesis is not fully understood at least in neurons of the central nervous system. Protein synthesis is activated in different cell types by a variety of growth factors essential to cell growth, differentiation, and survival. Translational control starts at the level of initiation (1, 2) and depends on eukaryotic initiation factor 2 (eIF2).1 This binds to GTP and interacts with the initiator methionyl-tRNA (Met-tRNA i ) to form the ternary complex eIF2⅐GTP⅐Met-tRNA i . In this way, eIF2 factor recruits Met-tRNA i to the 40 S ribosomal subunit. This together with other initiation factors binds to mRNA, leading to the recognition of the AUG start codon (3-5). Upon formation of the 80 S initiation complex, GTP is hydrolyzed, and eIF2 is released from the ribosome as a functionally inactive binary complex (eIF2⅐GDP). Eukaryotic initiation factor 2B (eIF2B) is a heteropentameric protein that catalyzes the exchange of bound GDP from eIF2⅐GDP for GTP (4, 6, 7). The eIF2⅐GTP form is then available to undergo further interaction with Met-tRNA i , leading to a new round of initiation. eIF2B activity therefore plays a key role in regulating translation initiation. elF2B factor can be ma...